Phase 3 Trial: Avasopasem Manganese

Carryn Anderson at ASTRO 2022

Dr Anderson shared the results of the Phase 3 Trial of Avasopasem Manganese (GC4419) to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer at the ASTRO Annual Meeting, 2022. The next development will seek to obtain FDA approval for this treatment!

Monday, October 31, 2022